Vermont has been active in cost containment and transparency through a number of state planning initiatives, rate and premium control, and the VHCURES all-payer claims database. Vermont also attempted to be the first state to operate a single-payer healthcare system, however, the state gave up on the plan in 2014. In the 2017 legislative term, Vermont proposed legislation to create a public option, increase transparency on prescription drug pricing, and curb the State’s spending of prescription drugs to no higher than the Department of Veteran Affairs. However none of these proposals carried on into the next legislative term.
In the 2018 legislative term, Vermont passed legislation to allow the wholesale purchase of prescription drugs from Canada and to create a state mandate for minimum essential health care. The mandate to require all residents to have health insurance will take affect in January 2010 and is designed to keep healthier people enrolled in the states’ Affordable Care Act insurance marketplaces and premium prices low. In addition, the Legislature also passed a drug price transparency bill (S 92) which requires state officials to identify 15 drugs whose wholesale acquisition costs rose by 50 percent or more over the last five years, and 15 medicines that rose 15 percent or more over a 12-month period. The drugs’ makers must justify the price increases to the state’s attorney general and the information is made public.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare. We currently cover bills from the 2017-2018 legislative term and key statutes from each state. Search the database for specific bills, statutes or cases by using keyword, key issue category, and/or jurisdiction.